CellCentric vs Degron Therapeutics
CellCentric vs Degron Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Degron Therapeutics on 62/100.
Where each one leads
CellCentric
- agent readiness: 32/100 against 27/100
- domain rating: 35/100 against 24/100
- headcount: 53 against 24
- funding raised: $375M against $40.0M
- LinkedIn following: 28,695 against 1,380
Degron Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CellCentric | Degron Therapeutics |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma. | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2003 | 2020 |
| Headquarters | Cambridge, United Kingdom | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | CellCentric | Degron Therapeutics |
|---|---|---|
| Employees | 53 | 24 |
| Total funding | $375M | $40.0M |
| Latest round | Series D | Series A Extension |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 28,695 | 1,380 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CellCentric | Degron Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 62/100 |
| Traction | 57/100 | Not published |
| Team | 60/100 | 24/100 |
| Search visibility | 44/100 | 57/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CellCentric | Degron Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CellCentric vs Degron Therapeutics: common questions
Which is better, CellCentric or Degron Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CellCentric and Degron Therapeutics compare on the numbers?
CellCentric leads on agent readiness (32/100 against 27/100), domain rating (35/100 against 24/100), headcount (53 against 24), funding raised ($375M against $40.0M), LinkedIn following (28,695 against 1,380).
Read the full CellCentric review and pricing or the Degron Therapeutics review and pricing. You can also browse other CellCentric alternatives we track.